Company Intelligence
Exscientia
Exscientia provides enterprise-grade artificial intelligence solutions, delivering specialized Exscientia Platform technology designed to optimize mission-critical workflows across now internal to recursion pharmaceuticals; historically pharmaceutical partners seeking ai-designed clinical candidates..
- Headquarters
- Oxford, United Kingdom
- Website
- www.exscientia.com
- Founded
- 2012
- Status
- Acquired
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Founded in 2012 in United Kingdom, Exscientia is an applied Artificial Intelligence company that develops and scales Exscientia Platform for Now internal to Recursion Pharmaceuticals; historically pharmaceutical partners seeking AI-designed clinical candidates..
What it does
Through the deployment of Exscientia Platform, Exscientia provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
Who it serves
Now internal to Recursion Pharmaceuticals; historically pharmaceutical partners seeking AI-designed clinical candidates.
What it builds
Exscientia Platform
Why It Matters
Exscientia provides enterprise-grade artificial intelligence solutions, delivering specialized Exscientia Platform technology designed to optimize mission-critical workflows across now internal to recursion pharmaceuticals; historically pharmaceutical partners seeking ai-designed clinical candidates..
Products
Products and platforms connected to this company.
-
Exscientia — Biotechnology
Explore Exscientia — Biotechnology by Exscientia. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Exscientia
Industry
Industries served
- Biotechnology
Products
Capabilities
Exscientia's AI stack focused on active learning for molecule design — iteratively synthesizing and testing compounds suggested by models rather than screening…
Features
AI-driven precision drug design platform automating target selection, molecule generation, and synthesis planning — integrated into Recursion post-acquisition.
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Frequently Asked Questions
What does Exscientia do?
Exscientia specializes in artificial intelligence, developing Exscientia Platform to support now internal to recursion pharmaceuticals; historically pharmaceutical partners seeking ai-designed clinical candidates. with scalable, production-grade technology.
Where is Exscientia based and when was it founded?
Exscientia is based in United Kingdom and was founded in 2012.
What are the main products offered by Exscientia?
The flagship platform from Exscientia is Exscientia Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Exscientia?
Exscientia primarily serves now internal to recursion pharmaceuticals; historically pharmaceutical partners seeking ai-designed clinical candidates. seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.